These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 638311)
21. Determination of 3-methoxytyramine in rat brain by HPLC with electrochemical detection and its correlation with dopamine function after administration of a monoamine oxidase inhibitor and L-3,4-dihydroxyphenylalanine. Davies CL; Heal DJ J Neurochem; 1986 Dec; 47(6):1919-23. PubMed ID: 3772383 [TBL] [Abstract][Full Text] [Related]
22. Elevation of brain GABA concentrations with amino-oxyacetic acid; effect on the hyperactivity syndrome produced by increased 5-hydroxytryptamine synthesis in rats. Green AR; Tordoff AF; Bloomfield MR J Neural Transm; 1976; 39(1-2):103-12. PubMed ID: 988113 [TBL] [Abstract][Full Text] [Related]
23. Brain noradrenaline depletion prevents ECS-induced enhancement of serotonin- and dopamine-mediated behaviour. Green AR; Deakin JF Nature; 1980 May; 285(5762):232-3. PubMed ID: 7374776 [TBL] [Abstract][Full Text] [Related]
24. The role of noradrenaline, dopamine and 5-hydroxytryptamine in the hyperactivity response resulting from the administration of tranylcypramine to rats pretreated with lithium or rubidium. Judd A; Parker J; Jenner FA Psychopharmacologia; 1975 Apr; 42(1):73-7. PubMed ID: 1153625 [TBL] [Abstract][Full Text] [Related]
25. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--II. The effects of anaesthesia and current conditions on the appearance of enhanced responses following electroconvulsive shock. Cowen PJ; Nutt DJ; Green AR Neuropharmacology; 1980 Sep; 19(9):901-6. PubMed ID: 7422101 [No Abstract] [Full Text] [Related]
26. Inhibition of 5-hydroxytryptamine-mediated behaviour by the putative 5-HT2 antagonist pirenperone. Green AR; O'Shaughnessy K; Hammond M; Schächter M; Grahame-Smith DG Neuropharmacology; 1983 May; 22(5):573-8. PubMed ID: 6603593 [TBL] [Abstract][Full Text] [Related]
27. Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat. Ainsworth K; Smith SE; Sharp T J Psychopharmacol; 1998; 12(3):252-7. PubMed ID: 10958251 [TBL] [Abstract][Full Text] [Related]
28. The effect of estradiol on the alterations in monoamine-mediated behavioural responses induced by administration of electroconvulsive shocks or imipramine to female rats. Bhavsar VH; Dhumal VR; Kelkar VV Neuropharmacology; 1983 Jun; 22(6):751-6. PubMed ID: 6684220 [TBL] [Abstract][Full Text] [Related]
29. Enhanced 5-hydroxytryptamine and dopamine-mediated behavioural responses following convulsions--III. The effects of monoamine antagonists and synthesis inhibitors on the ability of electroconvulsive shock to enhance responses. Green AR; Costain DW; Deakin JF Neuropharmacology; 1980 Sep; 19(9):907-14. PubMed ID: 7422102 [No Abstract] [Full Text] [Related]
30. Pharmacological studies on serotonin-mediated behaviour. Green AR J Physiol (Paris); 1981; 77(2-3):437-47. PubMed ID: 6457143 [TBL] [Abstract][Full Text] [Related]
31. Proceedings: The role of brain dopamine in the hyperactivity syndrome produced in rats after administration of L-tryptophan and a monoamine oxidase inhibitor. Grahame-Smith DG; Green AR Br J Pharmacol; 1974 Mar; 50(3):442P-443P. PubMed ID: 4853875 [No Abstract] [Full Text] [Related]
32. Further evidence for a relationship between changes in GABA concentration in rat brain and enhanced monoamine-mediated behavioural responses following repeated electroconvulsive shock. Green AR; Sant K; Bowdler JM; Cowen PJ Neuropharmacology; 1982 Oct; 21(10):981-4. PubMed ID: 7145036 [TBL] [Abstract][Full Text] [Related]
33. Neurochemical correlates of behavioral sensitization following repeated apomorphine treatment: assessment of the role of D1 dopamine receptor stimulation. Rowlett JK; Mattingly BA; Bardo MT Synapse; 1993 Jun; 14(2):160-8. PubMed ID: 8332946 [TBL] [Abstract][Full Text] [Related]
34. The effect of some anti-epilepsy drugs on enhancement of the monoamine-mediated behavioural responses following the administration of electroconvulsive shocks to rats. Bhavsar VH; Dhumal VR; Kelkar VV Eur J Pharmacol; 1981 Sep; 74(2-3):243-7. PubMed ID: 7327204 [TBL] [Abstract][Full Text] [Related]
35. Influence of neonatal and adult hyperthyroidism on behavior and biosynthetic capacity for norepinephrine, dopamine and 5-hydroxytryptamine in rat brain. Rastogi RB; Singhal RL J Pharmacol Exp Ther; 1976 Sep; 198(3):609-18. PubMed ID: 978462 [TBL] [Abstract][Full Text] [Related]
36. Effect of acute and chronic tri-iodothyronine (T3) administration to rats on central 5-HT and dopamine-mediated behavioural responses and related brain biochemistry. Atterwill CK Neuropharmacology; 1981 Feb; 20(2):131-44. PubMed ID: 7193809 [No Abstract] [Full Text] [Related]
37. Are convulsant gases also anesthetics? Koblin DD; Eger EI; Johnson BH; Collins P; Terrell RC; Speers L Anesth Analg; 1981 Jul; 60(7):464-70. PubMed ID: 7195661 [TBL] [Abstract][Full Text] [Related]
38. Biochemical and behavioural studies on the interference between catecholaminergic and serotonergic central systems. Allikmets LH; Zharkovsky AM Ann Ist Super Sanita; 1978; 14(1):63-70. PubMed ID: 40501 [TBL] [Abstract][Full Text] [Related]
39. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine. Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306 [TBL] [Abstract][Full Text] [Related]
40. Chronic phenytoin and the stereotyped motor response induced by 5-methoxy-N,N-dimethyltryptamine in rats. Lalonde R; Botez MI Brain Res; 1985 Feb; 326(2):388-91. PubMed ID: 4038621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]